$CNSP 8-K SEC Filings

Filed On	Filing
02 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders 1.1 The Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) established the CNS Pharmaceuticals, Inc. 2020 Equity Plan (the “Plan”) effective as of April 6, 2020, which was approved by the Company’s stockholders at the Compan...
02 Jul 2026	8-K: Regulation FD Disclosure
04 May 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
11 Mar 2026	8-K: Regulation FD Disclosure
02 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
21 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
22 Jul 2025	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
15 Jul 2025	8-K: Regulation FD Disclosure
15 May 2025	8-K: Entry into a Material Definitive Agreement
09 Apr 2025	8-K: Regulation FD Disclosure
31 Mar 2025	8-K: Other Events
20 Mar 2025	8-K: Other Events
21 Feb 2025	8-K: Material Modification to Rights of Security Holders; Other Events
03 Jan 2025	8-K: Regulation FD Disclosure; Other Events
11 Dec 2024	8-K: Regulation FD Disclosure
03 Dec 2024	8-K: Submission of Matters to a Vote of Security Holders
01 Nov 2024	8-K: Other Events
24 Oct 2024	8-K: Entry into a Material Definitive Agreement; Other Events

Comments